The IPO of Scripps Safe, Inc represents a significant milestone for the company, potentially attracting investor interest due to its niche in pharmaceutical supply chain solutions. The pricing of shares between $4.00 and $6.00 offers an accessible entry point for investors, while the insider lock-up period indicates a commitment from insiders to hold onto their shares, suggesting confidence in the company's future performance. However, as with any IPO, there's inherent risk and uncertainty, especially in the short term.